Naphazoline (Akorn, Inc.)
Welcome to the PulseAid listing for the Naphazoline drug offered from Akorn, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Akorn, Inc. |
| NON-PROPRIETARY NAME: | Naphazoline Hydrochloride |
| SUBSTANCE NAME: | NAPHAZOLINE HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | SOLUTION/ DROPS |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 1995-12-19 |
| END MARKETING DATE: | 0000-00-00 |
Naphazoline HUMAN PRESCRIPTION DRUG Details:
| Item Description | Naphazoline from Akorn, Inc. |
| LABELER NAME: | Akorn, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 1995-12-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 17478-216_70e961a5-5aab-4ce7-b564-b8c2a89da1d3 |
| PRODUCT NDC: | 17478-216 |
| APPLICATION NUMBER: | ANDA083590 |
Other NAPHAZOLINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
